| Name | Sector |
Revenue
$mlns |
M&A Activity | Last 5 Years | ||
|---|---|---|---|---|---|---|
| Total | Buy | Sell | ||||
SIX Swiss Exchange : RHHBY Basel, Switzerland website |
Life Science | 64,831 | 46 | 44 | 2 |
|
NYSE : NVS Basel, Switzerland website |
Life Science | 51,772 | 44 | 36 | 8 |
|
Public Basel, Switzerland website |
Life Science | 6,831 | 17 | 12 | 5 |
|
|
Siegfried Holding
SIX Swiss Exchange : SFZN Zofingen, Switzerland website |
Life Science | 1,346 | 2 | 2 | - |
|
|
Evolva
SIX Swiss Exchange : EVE Reinach, Switzerland website |
Life Science | 9 | 3 | 2 | 1 |
|
|
AC Immune
NASDAQ : ACIU Lausanne, Switzerland website |
Life Science | 27 | 1 | 1 | - |
|
|
ADC Therapeutics
NYSE : ADCT Epalinges, Switzerland website |
Life Science | 71 | - | - | - |
|
|
NLS Pharmaceutics
NASDAQ : NLSP Zurich, Switzerland website |
Life Science | 12 | - | - | - |
|
|
Molecular Partners
NASDAQ : MOLN Schlieren, Switzerland website |
Life Science | 5 | - | - | - |
|
|
Xlife Sciences
SIX Swiss Exchange : XLS Zürich, Switzerland website |
Life Science | 1 | 1 | - | 1 |
|
|
Basilea Pharmaceutica
SIX Swiss Exchange : BSLN Allschwil, Switzerland website |
Life Science | 217 | - | - | - |
|
|
ObsEva
Public Geneva, Switzerland website |
Life Science | 21 | - | - | - |
|
Mergr was built to make it easy to understand who owns which companies — and how they got there.
Whether you're researching private equity-backed businesses, recent acquisitions, or potential targets, Mergr provides structured access to thousands of companies, investors, and ownership histories.
The platform is powerful but easy to use — so you can quickly surface relevant companies and move from research to action.
Full access to Mergr's investor, acquirer, and transaction data starts here.